Trial Profile
A phase I trial evaluating relative bioavailability of ITI-214 with or without food in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 May 2018
Price :
$35
*
At a glance
- Drugs Lenrispodun (Primary)
- Indications Dementia; Schizophrenia
- Focus Pharmacokinetics
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology
- 25 Sep 2015 New trial record